Chin-Chou Huang Selected Research

Type I Tumor Necrosis Factor Receptors

3/2024	Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.
1/2023	Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus.
10/2020	Soluble Tumor Necrosis Factor Receptor Type 1 Levels Exhibit A Stronger Association With Renal Outcomes Than Traditional Risk Factors in Chinese Subjects With Type 2 Diabetes Mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chin-Chou Huang Research Topics

Disease

15	Hypertension (High Blood Pressure) 01/2022 - 04/2011
13	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 06/2010
13	Heart Failure 12/2023 - 01/2016
11	Myocardial Infarction 07/2023 - 01/2012
10	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 10/2011
8	Stroke (Strokes) 05/2024 - 03/2013
7	Type 2 Diabetes Mellitus (MODY) 03/2024 - 11/2009
7	Ischemic Stroke 01/2022 - 12/2012
5	Diabetic Nephropathies (Diabetic Nephropathy) 03/2024 - 01/2018
5	Inflammation (Inflammations) 01/2022 - 05/2011
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 12/2011
5	Atrial Fibrillation 12/2020 - 03/2010
4	Atherosclerosis 12/2022 - 07/2016
4	Diabetes Mellitus 01/2022 - 05/2011
3	Death (Near-Death Experience) 12/2023 - 01/2020
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2012
3	Chronic Renal Insufficiency 01/2018 - 05/2011
3	Neoplasms (Cancer) 01/2013 - 04/2011
2	Necrosis 11/2023 - 01/2022
2	Fibrosis (Cirrhosis) 01/2022 - 12/2011
2	Hypercholesterolemia 03/2020 - 07/2014
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2014 - 10/2013
2	Asthma (Bronchial Asthma) 09/2014 - 05/2011
2	Peptic Ulcer (Peptic Ulcers) 01/2013 - 12/2011
2	Hemorrhage 01/2013 - 12/2011
2	Non-alcoholic Fatty Liver Disease 01/2012 - 12/2010
1	Infections 05/2024
1	Anemia 10/2023
1	Vascular Calcification 10/2023
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 10/2023
1	Hemolytic Anemia 01/2023
1	Hemolysis 01/2023
1	Cardiac Tamponade 08/2022
1	Dyspnea (Shortness of Breath) 08/2022
1	Pleural Effusion (Pleural Effusions) 08/2022
1	Pericarditis 08/2022
1	Fatigue 08/2022
1	Arteriovenous Fistula 01/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2022
1	Albuminuria 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Hypertensive Nephropathy 01/2022

Drug/Important Bio-Agent (IBA)

9	omega-Chloroacetophenone (Mace)IBA 12/2023 - 01/2020
6	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 11/2009
5	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2009
5	LipidsIBA 12/2022 - 10/2015
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 05/2011
4	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2022 - 08/2014
3	Type I Tumor Necrosis Factor ReceptorsIBA 03/2024 - 10/2020
3	C-Reactive ProteinIBA 11/2023 - 12/2010
3	LDL CholesterolIBA 12/2022 - 01/2019
3	fibroblast growth factor 21IBA 01/2022 - 01/2016
3	ThiazidesIBA 01/2016 - 01/2013
3	Angiotensin Receptor AntagonistsIBA 08/2015 - 04/2011
2	AlbuminsIBA 03/2024 - 11/2020
2	Triglycerides (Triacylglycerol)IBA 10/2023 - 01/2012
2	ReninIBA 01/2022 - 01/2013
2	BilirubinIBA 11/2020 - 07/2016
2	Indicators and Reagents (Reagents)IBA 03/2020 - 12/2012
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2016 - 01/2013
2	Insulin (Novolin)FDA Link 12/2014 - 04/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2014 - 09/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2013 - 01/2013
2	erucylphosphocholineIBA 01/2013 - 01/2012
2	Clopidogrel (Plavix)FDA Link 01/2013 - 06/2010
1	CreatinineIBA 03/2024
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 11/2023
1	Interleukin-6 (Interleukin 6)IBA 11/2023
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2023
1	AdiponectinIBA 11/2023
1	Hemoglobins (Hemoglobin)IBA 10/2023
1	OsteocalcinIBA 10/2023
1	DiureticsIBA 01/2023
1	Furosemide (Lasix)FDA LinkGeneric 01/2023
1	oxidized low density lipoproteinIBA 12/2022
1	VaccinesIBA 08/2022
1	RNA (Ribonucleic Acid)IBA 08/2022
1	ChAdOx1 nCoV-19IBA 08/2022
1	NucleotidesIBA 01/2022
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	CholesterolIBA 01/2022
1	CytokinesIBA 01/2022
1	Nifedipine (Adalat)FDA LinkGeneric 01/2022
1	PTX3 proteinIBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2022
1	Chitinase-3-Like Protein 1IBA 01/2022
1	Lipocalin-2IBA 01/2022
1	SodiumIBA 01/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2022
1	CalciumIBA 01/2022
1	Member 3 Solute Carrier Family 12IBA 01/2022
1	AngiotensinsIBA 01/2022
1	Phosphates (Orthophosphate)IBA 10/2021

Therapy/Procedure

9	Therapeutics 07/2023 - 01/2013
8	Percutaneous Coronary Intervention 12/2023 - 06/2010
3	Renal Dialysis (Hemodialysis) 10/2023 - 12/2011
2	Catheter Ablation 02/2013 - 03/2010
1	Catheters 08/2022